Petra Bizikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Petra Bizikova has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Keith Emerson Linder
North Carolina State University
8 shared publications Lisa B. Mamo
Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
8 shared publications- Thierry Olivry
Department of Clinical Sciences, College of Veterinary Medicine, NC State University
8 shared publications - Ina Herrmann
Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
6 shared publications Keith E. Linder
College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
5 shared publications- Britt J. Levy
Department of Clinical Sciences, College of Veterinary Medicine, NC State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA
3 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (6) , 998-1004
Systemic Inflammation in Dogs With Atopic Dermatitis Compared to Healthy Dogs and Dogs With Pemphigus Foliaceus: A Study Using a Limited Cytokine Panel
Background: Atopic dermatitis (AD) is a common chronic, pruritic and inflammatory skin disease in both humans and dogs. In people, AD is increasingly recognised as a systemic inflammatory disease in which immune dysregulation drives chronic inflammation extending beyond the skin, particularly in moderate‐to‐severe disease. Whether a comparable systemic inflammation exists in canine AD, however, remains poorly characterised. Hypothesis/Objectives: We hypothesised that serum cytokine concentrations would differ between dogs with varying AD severity and healthy controls. This study aimed to identify systemic inflammatory markers correlating with AD severity, by comparing cytokine profiles in dogs with mild AD and moderate‐to‐severe AD against healthy dogs (negative control) and dogs with active pemphigus foliaceus (PF) lesions (positive control). Animals: Forty client‐owned dogs were enrolled, with 10 dogs in each of four groups: healthy controls, mild AD, moderate‐to‐severe AD and PF. Materials and Methods: Serum concentrations of tumour necrosis factor (TNF)‐α, TNF‐β/lymphotoxin‐α, interleukin (IL)‐1β, IL‐6, IL‐12 and IL‐1 receptor antagonist (IL‐1RA) were measured using standardised immunoassays to evaluate systemic inflammation across groups. Results: Marked interindividual variability was observed across all groups. No statistically significant differences in serum concentrations of any of the six cytokines were detected between the healthy, mild AD, moderate‐to‐severe AD and PF groups. Conclusions and Clinical Relevance: In a limited cytokine panel, no evidence of differential systemic inflammation was detected across groups, including dogs with moderate‐to‐severe AD compared to healthy controls. These findings may reflect true lack of systemic inflammation in dogs or may be attributable to the small sample size, high interindividual variability or the limited scope of the cytokine panel evaluated.
- 3 September 2026
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (6) , 998-1004
Open AccessSystemic Inflammation in Dogs With Atopic Dermatitis Compared to Healthy Dogs and Dogs With Pemphigus Foliaceus: A Study Using a Limited Cytokine Panel
Background: Atopic dermatitis (AD) is a common chronic, pruritic and inflammatory skin disease in both humans and dogs. In people, AD is increasingly recognised as a systemic inflammatory disease in which immune dysregulation drives chronic inflammation extending beyond the skin, particularly in moderate‐to‐severe disease. Whether a comparable systemic inflammation exists in canine AD, however, remains poorly characterised. Hypothesis/Objectives: We hypothesised that serum cytokine concentrations would differ between dogs with varying AD severity and healthy controls. This study aimed to identify systemic inflammatory markers correlating with AD severity, by comparing cytokine profiles in dogs with mild AD and moderate‐to‐severe AD against healthy dogs (negative control) and dogs with active pemphigus foliaceus (PF) lesions (positive control). Animals: Forty client‐owned dogs were enrolled, with 10 dogs in each of four groups: healthy controls, mild AD, moderate‐to‐severe AD and PF. Materials and Methods: Serum concentrations of tumour necrosis factor (TNF)‐α, TNF‐β/lymphotoxin‐α, interleukin (IL)‐1β, IL‐6, IL‐12 and IL‐1 receptor antagonist (IL‐1RA) were measured using standardised immunoassays to evaluate systemic inflammation across groups. Results: Marked interindividual variability was observed across all groups. No statistically significant differences in serum concentrations of any of the six cytokines were detected between the healthy, mild AD, moderate‐to‐severe AD and PF groups. Conclusions and Clinical Relevance: In a limited cytokine panel, no evidence of differential systemic inflammation was detected across groups, including dogs with moderate‐to‐severe AD compared to healthy controls. These findings may reflect true lack of systemic inflammation in dogs or may be attributable to the small sample size, high interindividual variability or the limited scope of the cytokine panel evaluated.
- Open Access
- 14 May 2026
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (4) , 511-521
Longitudinal Analysis of Seasonal Variations in Intradermal Test Reactivity and Serum Allergen‐Specific Immunoglobulin E in Dogs With Atopic Dermatitis
Background: In dogs with atopic dermatitis (AD), allergen testing is often timed to pollen exposure. However, data on seasonal effects on intradermal testing (IDT) and allergen‐specific immunoglobulin (Ig)E serology (SAT) are limited. Objectives: To evaluate the seasonal effects on IDT and SAT results in dogs with AD by comparing aeroallergen test positivity across four seasons within the same cohort. Animals: Twenty‐six client‐owned dogs with nonseasonal AD (six) and AD with seasonal pattern (20). Materials and Methods: In this prospective longitudinal study, dogs underwent repeated IDT and SAT using two commercial assays during spring, summer, autumn and winter. Seasonal differences in overall and allergen group‐specific positivity were analysed using nonparametric statistics and mixed‐effects and generalised estimating equation models. Results: There was modest seasonal variation in overall ( p = 0.004) and pollen‐specific reactions ( p = 0.005) on IDT, with autumn having the highest positivity rates. This pattern was seen only in dogs with a seasonal component to their AD ( p = 0.007). Grass and weed allergens had higher odds of testing positive in autumn (odds ratio [OR] = 2.696, p = 0.032 and OR = 2.026, p = 0.034, respectively), while other allergens showed no consistent seasonal differences. No significant seasonal differences were detected in SAT, although subtle effects could have been missed owing to the sample size and conservative statistical adjustments. Disease duration did not influence seasonal testing patterns. Conclusions and Clinical Relevance: These findings suggest that, until further data are available, allergen testing in dogs, especially those with seasonal AD, may be optimally timed later in the season (autumn) to increase the likelihood of positive results.
- 14 May 2026
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (4) , 511-521
Open AccessLongitudinal Analysis of Seasonal Variations in Intradermal Test Reactivity and Serum Allergen‐Specific Immunoglobulin E in Dogs With Atopic Dermatitis
Background: In dogs with atopic dermatitis (AD), allergen testing is often timed to pollen exposure. However, data on seasonal effects on intradermal testing (IDT) and allergen‐specific immunoglobulin (Ig)E serology (SAT) are limited. Objectives: To evaluate the seasonal effects on IDT and SAT results in dogs with AD by comparing aeroallergen test positivity across four seasons within the same cohort. Animals: Twenty‐six client‐owned dogs with nonseasonal AD (six) and AD with seasonal pattern (20). Materials and Methods: In this prospective longitudinal study, dogs underwent repeated IDT and SAT using two commercial assays during spring, summer, autumn and winter. Seasonal differences in overall and allergen group‐specific positivity were analysed using nonparametric statistics and mixed‐effects and generalised estimating equation models. Results: There was modest seasonal variation in overall ( p = 0.004) and pollen‐specific reactions ( p = 0.005) on IDT, with autumn having the highest positivity rates. This pattern was seen only in dogs with a seasonal component to their AD ( p = 0.007). Grass and weed allergens had higher odds of testing positive in autumn (odds ratio [OR] = 2.696, p = 0.032 and OR = 2.026, p = 0.034, respectively), while other allergens showed no consistent seasonal differences. No significant seasonal differences were detected in SAT, although subtle effects could have been missed owing to the sample size and conservative statistical adjustments. Disease duration did not influence seasonal testing patterns. Conclusions and Clinical Relevance: These findings suggest that, until further data are available, allergen testing in dogs, especially those with seasonal AD, may be optimally timed later in the season (autumn) to increase the likelihood of positive results.
- Open Access
- 7 January 2026
- Published by Wiley in Case Reports in Veterinary Medicine
- Vol. 2026 (1)
A Cautionary Tale of Exophiala spinifera Infection in Two Cats: Case Reports and Literature Review
This case series reports two independent cases of Exophiala spinifera infection in adult male neutered domestic cats, both referred following misdiagnosis. To date, only six cases associated with this organism have been reported in domestic cats, excluding those described herein. These also represent the first documented cases of E. spinifera infection in cats in the United States. In both cases, a definitive etiologic diagnosis could not be made by cytology, histology, or fungal culture. Moreover, histologic features did not allow for clear classification of the lesions as phaeohyphomycosis or chromoblastomycosis. Ultimately, accurate identification of the fungal pathogen was achieved through molecular diagnostic testing, rather than conventional mycologic or microscopic methods. These cases underscore the importance of molecular diagnostics and inter‐institutional collaboration in the accurate identification of dematiaceous fungi, such as E. spinifera , particularly given their variable clinical and pathological presentations.
- 7 January 2026
- Published by Wiley in Case Reports in Veterinary Medicine
- Vol. 2026 (1)
Open AccessA Cautionary Tale of Exophiala spinifera Infection in Two Cats: Case Reports and Literature Review
This case series reports two independent cases of Exophiala spinifera infection in adult male neutered domestic cats, both referred following misdiagnosis. To date, only six cases associated with this organism have been reported in domestic cats, excluding those described herein. These also represent the first documented cases of E. spinifera infection in cats in the United States. In both cases, a definitive etiologic diagnosis could not be made by cytology, histology, or fungal culture. Moreover, histologic features did not allow for clear classification of the lesions as phaeohyphomycosis or chromoblastomycosis. Ultimately, accurate identification of the fungal pathogen was achieved through molecular diagnostic testing, rather than conventional mycologic or microscopic methods. These cases underscore the importance of molecular diagnostics and inter‐institutional collaboration in the accurate identification of dematiaceous fungi, such as E. spinifera , particularly given their variable clinical and pathological presentations.
- Open Access
- 24 November 2025
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (2) , 306-318
Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD sensitised to Dermatophagoides farinae (Df) . Animals: Fifteen dogs positive for Df only and 20 dogs with reactivity to additional environmental allergens received either a low (0.5 mg/0.1 mL) or high (2 mg/0.4 mL) dose of the vaccine intradermally. Materials and Methods: Four doses of vaccine were administered every 2 weeks. Pruritus, Canine Atopic Dermatitis Extent and Severity Index (CADESI)‐04, average daily medication scores (AvdMS) and adverse events (AE) were recorded over 24 weeks. Owner perception of treatment efficacy (OGATE) was assessed at the end. Results: Pruritus and CADESI‐04 improved regardless of the sensitisation profile and the vaccine dose. After 24 weeks, despite a statistically insignificant reduction of AvdMS, 71%, 46% and 86% of dogs reached PVAS < 3.6, PVAS < 2 and CADESI‐04 < 10, respectively. There was no statistically significant effect of AvdMS on PVAS or CADESI‐04, meaning that the concurrently administered topical and/or systemic treatment(s) were unlikely to have been responsible for the observed PVAS and CADESI‐04 reduction. Twenty‐one owners (60%) rated the vaccine efficacy as good‐to‐excellent. No severe AEs were reported. Conclusions and Clinical Relevance: These results of this proof‐of‐concept study support not only the safety of DNA vaccine immunotherapy in dogs with AD, but also its potential clinical benefits. A double‐blinded, ≥ 12 month long, controlled study with more subjects should follow to further confirm the true efficacy of this vaccine.
- 24 November 2025
- Published by Wiley in Veterinary Dermatology
- Vol. 37 (2) , 306-318
Open AccessEfficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD sensitised to Dermatophagoides farinae (Df) . Animals: Fifteen dogs positive for Df only and 20 dogs with reactivity to additional environmental allergens received either a low (0.5 mg/0.1 mL) or high (2 mg/0.4 mL) dose of the vaccine intradermally. Materials and Methods: Four doses of vaccine were administered every 2 weeks. Pruritus, Canine Atopic Dermatitis Extent and Severity Index (CADESI)‐04, average daily medication scores (AvdMS) and adverse events (AE) were recorded over 24 weeks. Owner perception of treatment efficacy (OGATE) was assessed at the end. Results: Pruritus and CADESI‐04 improved regardless of the sensitisation profile and the vaccine dose. After 24 weeks, despite a statistically insignificant reduction of AvdMS, 71%, 46% and 86% of dogs reached PVAS < 3.6, PVAS < 2 and CADESI‐04 < 10, respectively. There was no statistically significant effect of AvdMS on PVAS or CADESI‐04, meaning that the concurrently administered topical and/or systemic treatment(s) were unlikely to have been responsible for the observed PVAS and CADESI‐04 reduction. Twenty‐one owners (60%) rated the vaccine efficacy as good‐to‐excellent. No severe AEs were reported. Conclusions and Clinical Relevance: These results of this proof‐of‐concept study support not only the safety of DNA vaccine immunotherapy in dogs with AD, but also its potential clinical benefits. A double‐blinded, ≥ 12 month long, controlled study with more subjects should follow to further confirm the true efficacy of this vaccine.
- 18 August 2025
- Published by Wiley in Veterinary Dermatology
- Vol. 36 (6) , 847-857
Retrospective Analysis of Cases of Probable Canine Cutaneous Toxic Shock Syndrome for Clues to Facilitate an Early Diagnosis
Background: Cutaneous toxic shock syndrome (CTSS), attributed to staphylococcal and streptococcal exotoxins, causes diffuse erythroderma and peripheral oedema with fatal systemic complications. In human medicine, a published list of scoring criteria exists where higher scores correlate with an increased likelihood of CTSS. Objectives: To describe clinical and clinicopathological findings in canine CTSS and to determine the validity of the human TSS criteria score in dogs. Animals: Seven client‐owned dogs were treated at two veterinary teaching hospitals between 2003 and 2023. Methods: Dogs with histopathological lesions of coalescing panepidermal cytotoxic dermatitis with neutrophilic satellitosis were included. Results: Diagnosis was made antemortem in four of seven and postmortem in three of seven. Prodromal clinical signs included lethargy (seven of seven), vomiting and/or diarrhoea (three of seven) and inappetence (three of seven). Primary skin lesions included diffuse erythroderma (seven of seven), ventral oedema (seven of seven), distal limb oedema (six of seven) and vesicles/bullae of the concave pinnae (three of seven), ventrum (one of seven) and perianally (one of seven). Clinicopathological changes included anaemia (seven of seven), neutropaenia (two of seven), neutrophilia (five of seven), hypoalbuminaemia (seven of seven), thrombocytopaenia (seven of seven), increased liver enzymes (six of seven) and azotaemia (four of seven). Blood cultures were negative in five of five dogs and the source of infection was not identified in any dog. Five of seven dogs died or were euthanised and had higher scores using human criteria than the remaining two dogs; these two survived with supportive care and antibiotics. Conclusions and Clinical Relevance: CTSS should be a differential diagnosis in dogs with the above prodromal signs before sudden onset of erythroderma, because early diagnosis is critical to survival. The human TSS criteria score could aid in earlier detection of canine CTSS.
- 18 August 2025
- Published by Wiley in Veterinary Dermatology
- Vol. 36 (6) , 847-857
Retrospective Analysis of Cases of Probable Canine Cutaneous Toxic Shock Syndrome for Clues to Facilitate an Early Diagnosis
Background: Cutaneous toxic shock syndrome (CTSS), attributed to staphylococcal and streptococcal exotoxins, causes diffuse erythroderma and peripheral oedema with fatal systemic complications. In human medicine, a published list of scoring criteria exists where higher scores correlate with an increased likelihood of CTSS. Objectives: To describe clinical and clinicopathological findings in canine CTSS and to determine the validity of the human TSS criteria score in dogs. Animals: Seven client‐owned dogs were treated at two veterinary teaching hospitals between 2003 and 2023. Methods: Dogs with histopathological lesions of coalescing panepidermal cytotoxic dermatitis with neutrophilic satellitosis were included. Results: Diagnosis was made antemortem in four of seven and postmortem in three of seven. Prodromal clinical signs included lethargy (seven of seven), vomiting and/or diarrhoea (three of seven) and inappetence (three of seven). Primary skin lesions included diffuse erythroderma (seven of seven), ventral oedema (seven of seven), distal limb oedema (six of seven) and vesicles/bullae of the concave pinnae (three of seven), ventrum (one of seven) and perianally (one of seven). Clinicopathological changes included anaemia (seven of seven), neutropaenia (two of seven), neutrophilia (five of seven), hypoalbuminaemia (seven of seven), thrombocytopaenia (seven of seven), increased liver enzymes (six of seven) and azotaemia (four of seven). Blood cultures were negative in five of five dogs and the source of infection was not identified in any dog. Five of seven dogs died or were euthanised and had higher scores using human criteria than the remaining two dogs; these two survived with supportive care and antibiotics. Conclusions and Clinical Relevance: CTSS should be a differential diagnosis in dogs with the above prodromal signs before sudden onset of erythroderma, because early diagnosis is critical to survival. The human TSS criteria score could aid in earlier detection of canine CTSS.
- Open Access
- 5 June 2024
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (5) , 524-535
Comparison of selected cytomorphological features of canine pemphigus foliaceus and superficial pyoderma
Background: Cytological detection of acantholytic keratinocytes (acantholytic cells [AC]) helps to identify canine pemphigus foliaceus (cPF) yet AC also occurs in superficial pyoderma (SP), the main differential diagnosis.Hypothesis/Objectives: To compare selected cytomorphological features of cPF and SP and to establish cytological diagnostic criteria that could differentiate cPF from SP.Animals: 40 and 51 client‐owned dogs with PF and SP, respectively.Materials and Methods: Impression smears from cPF (64), impetigo (40) and exfoliative superficial pyoderma (ESP) (17) samples were stained with Romanowsky stain, randomised, blinded and evaluated by two investigators independently. The entire sample was screened (×500 or ×1000 magnification) for round (AC1), boat (AC2) and raft AC, eosinophils and bacteria. Interobserver agreements were calculated.Results: The average number of the 10 highest ×500 fields for AC1 and AC2 was significantly higher in PF than SP (p < 0.0001; Kruskal–Wallis test). Rafts and eosinophils were more common in PF than SP (p < 0.0001; chi‐square test), while bacteria were rare in PF (5%; p < 0.0001; chi‐square test). Observations between the experienced and novice investigators were highly correlated. An ROC analysis identified five AC1/×500‐magnification field as a suitable cut‐off value for predicting PF diagnosis. This cut‐off value was tested by two additional investigators, who identified sensitivity of 84%–100%, specificity of 95%–97% and accuracy of 95%–96% for the diagnosis of cPF.Conclusions and Clinical Relevance: Criterion‐based impression smear cytological evaluation can provide strong evidence to support the clinical diagnosis. Acantholytic cell morphology varies in cPF and SP, and experience can improve accuracy in cytological differentiation.
- 5 June 2024
- Published by Wiley in Veterinary Dermatology
- Vol. 35 (5) , 524-535
Open AccessComparison of selected cytomorphological features of canine pemphigus foliaceus and superficial pyoderma
Background: Cytological detection of acantholytic keratinocytes (acantholytic cells [AC]) helps to identify canine pemphigus foliaceus (cPF) yet AC also occurs in superficial pyoderma (SP), the main differential diagnosis.Hypothesis/Objectives: To compare selected cytomorphological features of cPF and SP and to establish cytological diagnostic criteria that could differentiate cPF from SP.Animals: 40 and 51 client‐owned dogs with PF and SP, respectively.Materials and Methods: Impression smears from cPF (64), impetigo (40) and exfoliative superficial pyoderma (ESP) (17) samples were stained with Romanowsky stain, randomised, blinded and evaluated by two investigators independently. The entire sample was screened (×500 or ×1000 magnification) for round (AC1), boat (AC2) and raft AC, eosinophils and bacteria. Interobserver agreements were calculated.Results: The average number of the 10 highest ×500 fields for AC1 and AC2 was significantly higher in PF than SP (p < 0.0001; Kruskal–Wallis test). Rafts and eosinophils were more common in PF than SP (p < 0.0001; chi‐square test), while bacteria were rare in PF (5%; p < 0.0001; chi‐square test). Observations between the experienced and novice investigators were highly correlated. An ROC analysis identified five AC1/×500‐magnification field as a suitable cut‐off value for predicting PF diagnosis. This cut‐off value was tested by two additional investigators, who identified sensitivity of 84%–100%, specificity of 95%–97% and accuracy of 95%–96% for the diagnosis of cPF.Conclusions and Clinical Relevance: Criterion‐based impression smear cytological evaluation can provide strong evidence to support the clinical diagnosis. Acantholytic cell morphology varies in cPF and SP, and experience can improve accuracy in cytological differentiation.
- 14 May 2024
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 273, 110773
Re-evaluating the prevalence of anti-desmocollin-1 IgA autoantibodies in canine pemphigus foliaceus
- 14 May 2024
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 273, 110773
Re-evaluating the prevalence of anti-desmocollin-1 IgA autoantibodies in canine pemphigus foliaceus
- 13 July 2023
- Published by Springer Nature
- p. 537-553
Autoimmunerkrankungen
- Open Access
- 14 June 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 34 (5) , 425-440
Histopathological characterisation of trunk‐dominant canine pemphigus foliaceus, and comparison with classic facial and insecticide‐triggered forms
Background: While the clinical features were described recently, the histopathological characterisation of trunk‐dominant canine pemphigus foliaceus (PF) is lacking, and whether it differs from classic facial or insecticide‐triggered PF is unknown.Hypothesis/Objectives: This study describes the histopathological findings of trunk‐dominant PF, and compares the results to classic facial and insecticide‐triggered PF.Animals: Skin biopsies from 103 dogs with clinically characterised trunk‐dominant (n = 33), classic facial (n = 26) and insecticide‐triggered PF (n = 44) were included.Materials and Methods: Histological sections, randomised and blinded, were scored for over 50 morphological parameters of pustules, epidermis, dermis, adnexa and crusts. Intact pustule area and width were measured by digital microscopy.Results: In trunk‐dominant PF, 77 intact pustules were predominantly subcorneal (0.0019–1.940 mm2 area, 0.0470–4.2532 mm wide), and contained from one to over 100 acantholytic keratinocytes. Pustules had boat acantholytic cells, corneocytes, perinuclear eosinophilic rings, neutrophil rosettes, acantholytic cell necrosis, rafts, cling‐ons and/or eosinophils. Peripustular epidermal spongiosis, necrosis and lymphocyte exocytosis occurred, as did follicular pustules. Mixed dermal inflammation often contained eosinophils. Trunk‐dominant PF did not differ from the other PF groups except for few parameters, such as having fewer rafts (p = 0.003). Additional autoimmune inflammatory patterns occurred in all PF groups.Conclusions and Clinical Relevance: Trunk‐dominant PF and other canine PF variants are histologically similar, which indicates shared pathomechanisms. The identification of common boat acantholytic cells and corneocyte separation has implications for the mechanisms of acantholysis. The diversity of histopathological and polyautoimmunity features support complicated immune mechanisms. Finally, results indicate that diagnostic biopsies cannot differentiate between these PF variants in dogs.
- 14 June 2023
- Published by Wiley in Veterinary Dermatology
- Vol. 34 (5) , 425-440
Open AccessHistopathological characterisation of trunk‐dominant canine pemphigus foliaceus, and comparison with classic facial and insecticide‐triggered forms
Background: While the clinical features were described recently, the histopathological characterisation of trunk‐dominant canine pemphigus foliaceus (PF) is lacking, and whether it differs from classic facial or insecticide‐triggered PF is unknown.Hypothesis/Objectives: This study describes the histopathological findings of trunk‐dominant PF, and compares the results to classic facial and insecticide‐triggered PF.Animals: Skin biopsies from 103 dogs with clinically characterised trunk‐dominant (n = 33), classic facial (n = 26) and insecticide‐triggered PF (n = 44) were included.Materials and Methods: Histological sections, randomised and blinded, were scored for over 50 morphological parameters of pustules, epidermis, dermis, adnexa and crusts. Intact pustule area and width were measured by digital microscopy.Results: In trunk‐dominant PF, 77 intact pustules were predominantly subcorneal (0.0019–1.940 mm2 area, 0.0470–4.2532 mm wide), and contained from one to over 100 acantholytic keratinocytes. Pustules had boat acantholytic cells, corneocytes, perinuclear eosinophilic rings, neutrophil rosettes, acantholytic cell necrosis, rafts, cling‐ons and/or eosinophils. Peripustular epidermal spongiosis, necrosis and lymphocyte exocytosis occurred, as did follicular pustules. Mixed dermal inflammation often contained eosinophils. Trunk‐dominant PF did not differ from the other PF groups except for few parameters, such as having fewer rafts (p = 0.003). Additional autoimmune inflammatory patterns occurred in all PF groups.Conclusions and Clinical Relevance: Trunk‐dominant PF and other canine PF variants are histologically similar, which indicates shared pathomechanisms. The identification of common boat acantholytic cells and corneocyte separation has implications for the mechanisms of acantholysis. The diversity of histopathological and polyautoimmunity features support complicated immune mechanisms. Finally, results indicate that diagnostic biopsies cannot differentiate between these PF variants in dogs.
- 1 June 2023
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 261 (S1) , S48-S57
Erosive and ulcerative stomatitis in dogs and cats: which immune-mediated diseases to consider?
Immune-mediated and autoimmune diseases of the skin often present with oral cavity involvement. Autoimmune subepidermal blistering diseases and pemphigus vulgaris are classic examples. While the primary lesions (vesicles and bullae) are relatively specific, these fragile lesions evolve rapidly into erosions and ulcers, which are lesion types that overlap with many diseases. Furthermore, some immune-mediated diseases such as severe adverse drug reactions, lupus diseases, canine uveodermatological syndrome, and vasculitis, may or may not involve the oral cavity, and often nonoral clinical manifestations are more diagnostic. In these situations, disease knowledge combined with signalment, lesion distribution, and history help to narrow the differentials. Surgical biopsy is required for confirmation in most diseases, while immunosuppressive treatments most typically involve glucocorticoids with or without nonsteroidal immunosuppressants.
- 1 June 2023
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 261 (S1) , S48-S57
Erosive and ulcerative stomatitis in dogs and cats: which immune-mediated diseases to consider?
Immune-mediated and autoimmune diseases of the skin often present with oral cavity involvement. Autoimmune subepidermal blistering diseases and pemphigus vulgaris are classic examples. While the primary lesions (vesicles and bullae) are relatively specific, these fragile lesions evolve rapidly into erosions and ulcers, which are lesion types that overlap with many diseases. Furthermore, some immune-mediated diseases such as severe adverse drug reactions, lupus diseases, canine uveodermatological syndrome, and vasculitis, may or may not involve the oral cavity, and often nonoral clinical manifestations are more diagnostic. In these situations, disease knowledge combined with signalment, lesion distribution, and history help to narrow the differentials. Surgical biopsy is required for confirmation in most diseases, while immunosuppressive treatments most typically involve glucocorticoids with or without nonsteroidal immunosuppressants.